Discover the insights you need to make better decisions today, to shape the future with confidence.
See more
Attractiveness surveys
Why Europe’s confidence persists despite investment at a nine-year low
15 May 2025Julie Teigland
EY helps clients create long-term value for all stakeholders. Enabled by data and technology, our services and solutions provide trust through assurance and help clients transform, grow and operate.
Discover how EY insights and services are helping to reframe the future of your industry.
See more
At EY, our purpose is building a better working world. The insights and services we provide help to create long-term value for clients, people and society, and to build trust in the capital markets.
See more
Press release
09 Apr 2025Emile Abu-Shakra
Recent Searches
Trending
Does today’s disruption provide the blueprint for tomorrow’s growth?
EY-Parthenon CEO Survey September 2025 reveals how leaders build confidence, resilience, and growth strategies amid disruption and transformation.
18 Sep 2025 CEO agenda
How can trust survive without integrity?
The EY Global Integrity Report 2024 reveals that rapid change and economic uncertainty make it harder for companies to act with integrity. Read our findings.
06 Jun 2024
How to retake the momentum in the EV transition
The EY Mobility Consumer Index shows a slowdown in EV sales. Learn how consumer attitudes, policy and innovation can drive the next wave of EV adoption.
09 Sep 2024 AutomotiveEY Global Life Sciences Leader; EY EMEIA Life Sciences Market Lead
Passionate about driving health outcomes. Focused on making pharmaceutical innovations affordable and easily accessible to everyone.
As EY Global and EMEIA Life Sciences Sector Lead, Daniel is passionate about helping life sciences companies deliver better patient outcomes in the most efficient and effective way that can mutually benefit firms, payors, providers and patients.
Daniel started his career at a major pharmaceutical company and later in the NHS (National Health Service). Within pharma, Daniel managed the integration of the Welcome acquisition into Europe; implemented the UK pharmacy-agency distribution model, an industry first; managed a healthcare venture fund which sought to create physician-led companies; and then lead the sales and marketing for the European Neurology franchise. Within the NHS, Daniel created the first commercial clinical Site Management Organization that used the NHS’s unique data set to accelerate access to clinical trials.
Daniel earned a BSc (1st Hons) in Geography from the University of Bristol and an MSc in Computer and Information Science.
“Every day in the life sciences sector, I am able to see many opportunities to help build a better working world. Our challenge, however, is making sure that we focus our efforts on the transformational projects that will enable the greatest number of patients to gain access to the right treatments.”